Evelo Biosciences, Inc. (EVLO)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Evelo Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.271 |
| June 30, 2023 | -1.094 |
| March 31, 2023 | -1.851 |
| December 31, 2022 | -10.24 |
| September 30, 2022 | 5.877 |
| June 30, 2022 | 1.552 |
| March 31, 2022 | -3.323 |
| December 31, 2021 | 6.495 |
| September 30, 2021 | 1.716 |
| June 30, 2021 | 0.9215 |
| March 31, 2021 | 0.4711 |
| December 31, 2020 | 1.368 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.8335 |
| June 30, 2020 | 0.4707 |
| March 31, 2020 | 0.8382 |
| December 31, 2019 | 0.3262 |
| September 30, 2019 | 0.2427 |
| June 30, 2019 | 0.1484 |
| March 31, 2019 | 0.088 |
| December 31, 2018 | 0.0899 |
| September 30, 2018 | 0.0939 |
| June 30, 2018 | 0.0894 |
| March 31, 2018 | 0.1454 |
| December 31, 2017 | 0.3439 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |